La Jolla Pharmaceutical Company Information on lupus disease including a current clinical drug trial to test LJP 394, a novel therapeutic compound for systemic lupus erythematosus. Also, find information on a new compound to treat antibody-mediated stroke. Ljpc.com~Site InfoWhoisTrace RouteRBL Check